XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover Page - shares
 6 Months Ended
Jun. 30, 2023
Aug. 01, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2023  
Document Transition Report false  
Entity File Number 001-38085  
Entity Registrant Name Ovid Therapeutics Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 46-5270895  
Entity Address, Address Line One 441 Ninth Avenue  
Entity Address, Address Line Two 14th Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10001  
City Area Code 646  
Local Phone Number 661-7661  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol OVID  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   70,602,793
Entity Central Index Key 0001636651  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Amendment Flag false